Twin Tree Management, LP Intercept Pharmaceuticals, Inc. Transaction History

Twin Tree Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$77.77 - $120.68 $42,151 - $65,408	-542 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$91.83 - $120.68 $3,214 - $4,223	-35 Reduced 6.07%	542 $61,000
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $49,500 - $72,967	577 New	577 $58,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.